EGFR antagonists in cancer treatment

N Engl J Med. 2008 Mar 13;358(11):1160-74. doi: 10.1056/NEJMra0707704.

Authors

Fortunato Ciardiello¹, Giampaolo Tortora

Affiliation

¹ Division of Medical Oncology, Department of Experimental and Clinical Medicine and Surgery F. Magrassi and A. Lanzara, Second University of Naples, Naples, Italy. fortunato.ciardiello@unina2.it

PMID: 18337605
DOI: 10.1056/NEJMra0707704

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Review

MeSH terms

Antibodies, Monoclonal / pharmacology
Antibodies, Monoclonal / therapeutic use
Carcinoma, Non-Small-Cell Lung / drug therapy
Carcinoma, Squamous Cell / drug therapy
Colorectal Neoplasms / drug therapy
Drug Resistance
ErbB Receptors / antagonists & inhibitors*
ErbB Receptors / genetics
ErbB Receptors / physiology
Humans
Lung Neoplasms / drug therapy
Mutation
Neoplasms / drug therapy*
Pancreatic Neoplasms / drug therapy
Signal Transduction / physiology

Substances

Antibodies, Monoclonal
ErbB Receptors